Other Gastrointestinal Diseases

Show Only Open Trials
1.

LCD-CDAD-10-07: A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients with Clostridium difficile Associated Diarrhea

  • Study Status: Open to Enrollment
  • Sponsor: Cubist Pharmaceuticals
  • Disease Status and/or Stage: Clostridium Difficile Associated Diarrhea
  • Protocol ID: WCMC Protocol #1210013195; Sponsor Protocol # LCD-CDAD-10-07
2.

GS-US-321-0105: GS-6624 in the Treatment of Liver Fibrosis in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

  • Study Status: Open to Enrollment
  • Sponsor: Gilead
  • Disease Status and/or Stage: Advanced Liver Fibrosis as a Result of NASH (non-lcoholic steatohepatitis)
3.

GS-US-321-0102: GS-6624 in the Prevention of Progression of Liver Fibrosis in Subjects With With Primary Sclerosing Cholangitis (PSC)

  • Study Status: Open to Enrollment
  • Sponsor: Gilead
  • Disease Status and/or Stage: Primary Sclerosing Cholangtis (PSC)
  • Protocol ID: WCMC IRB #1302013540; Sponsor Protocol #GS-US-321-0102

Top of page